Brief: Aravive Announces Successful Completion Of Phase 1B Trial Evaluating Avb-500 In Platinum Resistant Ovarian Cancer
23/07/2020 12:18
July 23 (Reuters) - Aravive Inc ARAV.O :
* ARAVIVE ANNOUNCES SUCCESSFUL COMPLETION OF PHASE 1B TRIAL
EVALUATING AVB-500 IN PLATINUM RESISTANT OVARIAN CANCER
* ARAVIVE ANNOUNCES SUCCESSFUL COMPLETION OF PHASE 1B TRIAL
EVALUATING AVB-500 IN PLATINUM RESISTANT OVARIAN CANCER
Source text for Eikon: ID:nGNX6CNX7Y
Further company coverage: ARAV.O
((Reuters.Briefs@thomsonreuters.com;))